We have retained the Silver rating and increased our overall score this year at the EcoVadis Assessment, the world’s most […]
The Newsroom
News
India-headquartered molecular research specialists scale UK R&D capabilities in North West Expansion follows rapid business growth – with >50 new […]
24 Jun 2022
The criticality of Crystallisation process in the manufacture of drug substancesThe importance of crystallisation in the pharmaceutical and high-value chemical […]
7 Jun 2022
Outsourcing of R&D and Manufacturing has seen over a 50% budget increase in 2021, according to a report by CPhI, […]
11 Apr 2022
What is High Throughput Screening? The virtue of HTS If a methodology has to be nominated to the Science Hall […]
1 Mar 2022
An important physicochemical property for a drug compound is its Lipophilicity. This single property dictates many aspects of the performance […]
7 Feb 2022
Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO-CDMO), today announced the appointment of Sauri Gudlavalleti […]
19 Jan 2022
Dr. M. Damodharan, Chief Quality Officer at Sai Life Sciences participated in a webinar, presenting on the topic Regulatory Compliance […]
23 Dec 2021
Sai Life Sciences today announced the release of its 2021 Sustainability Report. Developed as per the Global Reporting Initiative (GRI) […]
20 Dec 2021
Sai Life Sciences today commenced recruitment for 100+ scientific positions across medicinal chemistry and biology to bolster the company’s growth […]
15 Dec 2021
Sai Life Sciences, a leading global Contract Research, Development & Manufacturing Organization (CRO/ CDMO), today announced that the Japanese regulatory […]
1 Dec 2021
Sai Life Sciences (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the […]
18 Sep 2025
As part of its Corporate Social Responsibility initiative, Sai Life Sciences has taken up the development of Kudikunta Lake in […]
5 Sep 2025
In a recent article published in Drug Target Review, Dr Santosh Kulkarni highlights the shift from injections to pills. He […]
5 Sep 2025
Sai Life Sciences Limited (BSE: 544306 | NSE: SAILIFE), an innovator-focused Contract Research, Development, and Manufacturing Organization (CRDMO), today announced the […]
28 Aug 2025
Sai Life Sciences Limited, an innovator focused Contract Research, Development, and Manufacturing Organization (CRDMO), announced that its near-term targets to […]